1301. Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
作者: Elias Eythorsson.;Saemundur Rognvaldsson.;Sigrun Thorsteinsdottir.;Thorir Einarsson Long.;Elin Ruth Reed.;Gudrun Asta Sigurdardottir.;Brynjar Vidarsson.;Pall Torfi Onundarson.;Bjarni A Agnarsson.;Margret Sigurdardottir.;Isleifur Olafsson.;Ingunn Thorsteinsdottir.;Signy Vala Sveinsdottir.;Fridbjorn Sigurdsson.;Asdis Rosa Thordardottir.;Runolfur Palsson.;Olafur Skuli Indridason.;Asbjorn Jonsson.;Gauti Kjartan Gislason.;Andri Olafsson.;Jon Sigurdsson.;Hlif Steingrimsdottir.;Malin Hultcrantz.;Brian G M Durie.;Stephen Harding.;Ola Landgren.;Thor Aspelund.;Thorvardur Jon Love.;Sigurdur Yngvi Kristinsson.
来源: Ann Intern Med. 2024年177卷4期449-457页
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are asymptomatic precursor conditions to multiple myeloma and related disorders. Smoldering multiple myeloma is distinguished from MGUS by 10% or greater bone marrow plasma cells (BMPC) on sampling, has a higher risk for progression, and requires specialist management.
1302. Management of Inpatient Elevated Blood Pressures : A Systematic Review of Clinical Practice Guidelines.
作者: Linnea M Wilson.;Shoshana J Herzig.;Michael A Steinman.;Mara A Schonberg.;Jennifer L Cluett.;Edward R Marcantonio.;Timothy S Anderson.
来源: Ann Intern Med. 2024年177卷4期497-506页
Management of elevated blood pressure (BP) during hospitalization varies widely, with many hospitalized adults experiencing BPs higher than those recommended for the outpatient setting.
1303. For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
Winer RL, Lin J, Anderson ML, et al. Strategies to increase cervical cancer screening with mailed human papillomavirus self-sampling kits: a randomized clinical trial. JAMA. 2023;330:1971-1981. 38015219.
1304. In adults with post-COVID-19 conditions, a synbiotic preparation, SIM01, alleviated some symptoms at 6 mo.
Lau RI, Su Q, Lau IS, et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2024;24:256-265. 38071990.
1305. Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
作者: Chad R Wells.;Abhishek Pandey.;Seyed M Moghadas.;Meagan C Fitzpatrick.;Burton H Singer.;Alison P Galvani.
来源: Ann Intern Med. 2024年177卷5期609-617页
The U.S. Food and Drug Administration has proposed administering annual SARS-CoV-2 vaccines.
1307. Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
作者: Jakob Weiss.;Vineet K Raghu.;Kaavya Paruchuri.;Aniket Zinzuwadia.;Pradeep Natarajan.;Hugo J W L Aerts.;Michael T Lu.
来源: Ann Intern Med. 2024年177卷4期409-417页
Guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend a risk calculator (ASCVD risk score) to estimate 10-year risk for major adverse cardiovascular events (MACE). Because the necessary inputs are often missing, complementary approaches for opportunistic risk assessment are desirable.
1308. Association of State Insulin Out-of-Pocket Caps With Insulin Cost-Sharing and Use Among Commercially Insured Patients With Diabetes : A Pre-Post Study With a Control Group.
作者: Laura F Garabedian.;Fang Zhang.;Rebecca Costa.;Stephanie Argetsinger.;Dennis Ross-Degnan.;J Frank Wharam.
来源: Ann Intern Med. 2024年177卷4期439-448页
Twenty-five states have implemented insulin out-of-pocket (OOP) cost caps, but their effectiveness is uncertain.
|